Parkinson's syndrome associated with neurofibrillary degeneration and tau pathologic findings
Identifieur interne : 004012 ( Main/Exploration ); précédent : 004011; suivant : 004013Parkinson's syndrome associated with neurofibrillary degeneration and tau pathologic findings
Auteurs : Andrew Lees (neurologue) [Royaume-Uni]Source :
- Movement Disorders [ 0885-3185 ] ; 2003-09.
Descripteurs français
- Pascal (Inist)
- Wicri :
- topic : Homme.
English descriptors
- KwdEn :
- Atypical, Brain (pathology), Diagnosis, Differential, Human, Humans, Mutation (genetics), Neurodegenerative Diseases (genetics), Neurodegenerative Diseases (pathology), Neurofibrillary tangle, Neurofibrils (genetics), Neurofibrils (pathology), PSP, Parkinson disease, Parkinsonian Disorders (genetics), Parkinsonian Disorders (pathology), Pathophysiology, Phenotype, Progressive, Supranuclear ophthalmoplegia, Symptomatology, Tau protein, Tauopathies (genetics), Tauopathies (pathology), atypical parkinsonism, bodig, bradykinesia, tau, tau Proteins (genetics), tau Proteins (metabolism).
- MESH :
- chemical , genetics : tau Proteins.
- genetics : Mutation, Neurodegenerative Diseases, Neurofibrils, Parkinsonian Disorders, Tauopathies.
- chemical , metabolism : tau Proteins.
- pathology : Brain, Neurodegenerative Diseases, Neurofibrils, Parkinsonian Disorders, Tauopathies.
- Diagnosis, Differential, Humans, Phenotype.
Abstract
Several distinct clinical syndromes presenting with parkinsonism have been associated with subcortical neurofibrillary degeneration and the abnormal accumulation of hyperphosphorylated tau protein in the brain. Mutations of tau have been linked with a small number of autosomal dominantly inherited families who present with frontolimbic cognitive deficits, behavioural disorders, and Parkinson's syndrome. Some of the sporadic disorders (progressive supranuclear palsy [PSP] and corticobasal degeneration) have been referred to by molecular pathologists as primary tauopathies, implicating abnormalities of tau in their pathogenesis. We have identified a sporadic parkinsonian syndrome characterised by bradykinesia, a variable response to levodopa, and a mean duration of disease of 9 years, which resembles bodig (Parkinson's–dementia of Guam), and histologically has close similarities with both PSP and postencephalitic parkinsonism. Further characterisation of these cases frequently confused with Parkinson's disease may broaden the clinical spectrum of parkinsonian disorders linked with neurofibrillary tangle formation. © 2003 Movement Disorder Society
Url:
DOI: 10.1002/mds.10560
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 001848
- to stream Istex, to step Curation: 001848
- to stream Istex, to step Checkpoint: 002942
- to stream PubMed, to step Corpus: 003715
- to stream PubMed, to step Curation: 003715
- to stream PubMed, to step Checkpoint: 003704
- to stream Ncbi, to step Merge: 000B49
- to stream Ncbi, to step Curation: 000B49
- to stream Ncbi, to step Checkpoint: 000B49
- to stream Main, to step Merge: 005C35
- to stream PascalFrancis, to step Corpus: 002380
- to stream PascalFrancis, to step Curation: 000941
- to stream PascalFrancis, to step Checkpoint: 002379
- to stream Main, to step Merge: 005F25
- to stream Main, to step Curation: 004012
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Parkinson's syndrome associated with neurofibrillary degeneration and tau pathologic findings</title><author><name sortKey="Lees, Andrew J" sort="Lees, Andrew J" uniqKey="Lees A" first="Andrew J." last="Lees">Andrew Lees (neurologue)</name><affiliation><country>Royaume-Uni</country><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName><orgName>National Hospital for Neurology and Neurosurgery</orgName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:103C6596D49525946F75A0063BE71A992FEF5EF0</idno><date when="2003" year="2003">2003</date><idno type="doi">10.1002/mds.10560</idno><idno type="url">https://api.istex.fr/document/103C6596D49525946F75A0063BE71A992FEF5EF0/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">001848</idno><idno type="wicri:Area/Istex/Curation">001848</idno><idno type="wicri:Area/Istex/Checkpoint">002942</idno><idno type="wicri:doubleKey">0885-3185:2003:Lees A:parkinson:s:syndrome</idno><idno type="wicri:source">PubMed</idno><idno type="RBID">pubmed:14502653</idno><idno type="wicri:Area/PubMed/Corpus">003715</idno><idno type="wicri:Area/PubMed/Curation">003715</idno><idno type="wicri:Area/PubMed/Checkpoint">003704</idno><idno type="wicri:Area/Ncbi/Merge">000B49</idno><idno type="wicri:Area/Ncbi/Curation">000B49</idno><idno type="wicri:Area/Ncbi/Checkpoint">000B49</idno><idno type="wicri:doubleKey">0885-3185:2003:Lees A:parkinson:s:syndrome</idno><idno type="wicri:Area/Main/Merge">005C35</idno><idno type="wicri:source">INIST</idno><idno type="RBID">Pascal:04-0081580</idno><idno type="wicri:Area/PascalFrancis/Corpus">002380</idno><idno type="wicri:Area/PascalFrancis/Curation">000941</idno><idno type="wicri:Area/PascalFrancis/Checkpoint">002379</idno><idno type="wicri:doubleKey">0885-3185:2003:Lees A:parkinson:s:syndrome</idno><idno type="wicri:Area/Main/Merge">005F25</idno><idno type="wicri:Area/Main/Curation">004012</idno><idno type="wicri:Area/Main/Exploration">004012</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Parkinson's syndrome associated with neurofibrillary degeneration and tau pathologic findings</title><author><name sortKey="Lees, Andrew J" sort="Lees, Andrew J" uniqKey="Lees A" first="Andrew J." last="Lees">Andrew Lees (neurologue)</name><affiliation wicri:level="3"><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Reta Lila Weston Institute of Neurological Studies, University College London, Windeyer Medical Institute, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName><orgName>National Hospital for Neurology and Neurosurgery</orgName></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="sub">Official Journal of the Movement Disorder Society</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2003-09">2003-09</date><biblScope unit="vol">18</biblScope><biblScope unit="issue">S6</biblScope><biblScope unit="supplement">6</biblScope><biblScope unit="page" from="28">28</biblScope><biblScope unit="page" to="33">33</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">103C6596D49525946F75A0063BE71A992FEF5EF0</idno><idno type="DOI">10.1002/mds.10560</idno><idno type="ArticleID">MDS10560</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Atypical</term><term>Brain (pathology)</term><term>Diagnosis, Differential</term><term>Human</term><term>Humans</term><term>Mutation (genetics)</term><term>Neurodegenerative Diseases (genetics)</term><term>Neurodegenerative Diseases (pathology)</term><term>Neurofibrillary tangle</term><term>Neurofibrils (genetics)</term><term>Neurofibrils (pathology)</term><term>PSP</term><term>Parkinson disease</term><term>Parkinsonian Disorders (genetics)</term><term>Parkinsonian Disorders (pathology)</term><term>Pathophysiology</term><term>Phenotype</term><term>Progressive</term><term>Supranuclear ophthalmoplegia</term><term>Symptomatology</term><term>Tau protein</term><term>Tauopathies (genetics)</term><term>Tauopathies (pathology)</term><term>atypical parkinsonism</term><term>bodig</term><term>bradykinesia</term><term>tau</term><term>tau Proteins (genetics)</term><term>tau Proteins (metabolism)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en"><term>tau Proteins</term></keywords><keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>Mutation</term><term>Neurodegenerative Diseases</term><term>Neurofibrils</term><term>Parkinsonian Disorders</term><term>Tauopathies</term></keywords><keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>tau Proteins</term></keywords><keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Brain</term><term>Neurodegenerative Diseases</term><term>Neurofibrils</term><term>Parkinsonian Disorders</term><term>Tauopathies</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Diagnosis, Differential</term><term>Humans</term><term>Phenotype</term></keywords><keywords scheme="Pascal" xml:lang="fr"><term>Atypique</term><term>Homme</term><term>Ophtalmoplégie supranucléaire</term><term>Parkinson maladie</term><term>Physiopathologie</term><term>Progressif</term><term>Protéine tau</term><term>Structure neurofibrillaire</term><term>Symptomatologie</term></keywords><keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Homme</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Several distinct clinical syndromes presenting with parkinsonism have been associated with subcortical neurofibrillary degeneration and the abnormal accumulation of hyperphosphorylated tau protein in the brain. Mutations of tau have been linked with a small number of autosomal dominantly inherited families who present with frontolimbic cognitive deficits, behavioural disorders, and Parkinson's syndrome. Some of the sporadic disorders (progressive supranuclear palsy [PSP] and corticobasal degeneration) have been referred to by molecular pathologists as primary tauopathies, implicating abnormalities of tau in their pathogenesis. We have identified a sporadic parkinsonian syndrome characterised by bradykinesia, a variable response to levodopa, and a mean duration of disease of 9 years, which resembles bodig (Parkinson's–dementia of Guam), and histologically has close similarities with both PSP and postencephalitic parkinsonism. Further characterisation of these cases frequently confused with Parkinson's disease may broaden the clinical spectrum of parkinsonian disorders linked with neurofibrillary tangle formation. © 2003 Movement Disorder Society</div></front></TEI><affiliations><list><country><li>Royaume-Uni</li></country><region><li>Angleterre</li><li>Grand Londres</li></region><settlement><li>Londres</li></settlement><orgName><li>National Hospital for Neurology and Neurosurgery</li></orgName></list><tree><country name="Royaume-Uni"><region name="Angleterre"><name sortKey="Lees, Andrew J" sort="Lees, Andrew J" uniqKey="Lees A" first="Andrew J." last="Lees">Andrew Lees (neurologue)</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004012 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 004012 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:103C6596D49525946F75A0063BE71A992FEF5EF0
|texte= Parkinson's syndrome associated with neurofibrillary degeneration and tau pathologic findings
}}
| This area was generated with Dilib version V0.6.23. |  |